AbbVie, University of Chicago team on cancer innovation effortsCHICAGO — AbbVie and the University of Chicago announced this week a new five-year collaboration to advance oncology medical research and improve the pace of discovery for both organizations. FDA approves Boehringer Ingelheim’s Gilotrif for squamous cell lung cancer SILVER SPRING, Md. — The Food and Drug Administration recently approved Boehringer Ingelheim Pharmaceuticals’ Gilotrif, a treatment for patients with advanced squamous cell carcinoma of the lung whose illness has progressed following platinum-based chemotherapy. The once-daily oral therapy had previously been approved as a first-line treatment for specific types of non-small cell lung cancer. GSK's ViiV Healthcare bolsters pipeline with several HIV assets from BMS Diplomat Pharmacy re-accredited by URAC Report: AstraZeneca acquires majority stake in cancer drug developer Diplomat personalizes specialty care with new Rare Disease Center of Excellence program 5 ways CVS will use personalization to evolve its Next-Gen Rx services Takeda announces Ninlaro US availability FDA approves Bendeka from Teva, Eagle Pharmaceuticals Survey: Employers taking action to cut specialty drug coverage First Previous 54 55 56 57 58 Next Last
